Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
1.940
+0.100 (5.43%)
Jun 23, 2026, 4:00 PM EDT - Market closed
Palisade Bio Market Cap
Palisade Bio has a market cap or net worth of $336.74 million as of June 23, 2026. Its market cap has increased by 9,978.77% in one year.
Market Cap
336.74M
Enterprise Value
204.12M
1-Year Change
9,978.77%
Ranking
Category
Stock Price
$1.94
Market Cap Chart
Since April 28, 2021, Palisade Bio's market cap has increased from $75.07M to $336.74M, an increase of 348.58%. That is a compound annual growth rate of 33.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 336.74M | -3.83% |
| Dec 31, 2025 | 350.16M | 7,572.39% |
| Dec 31, 2024 | 4.56M | -16.56% |
| Dec 29, 2023 | 5.47M | -31.77% |
| Dec 30, 2022 | 8.02M | -54.57% |
| Dec 31, 2021 | 17.65M | -76.49% |
| Apr 28, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Upstream Bio | 342.85M |
| OmniAb | 336.34M |
| Opus Genetics | 332.09M |
| Fennec Pharmaceuticals | 331.04M |
| Abeona Therapeutics | 327.72M |
| DiaMedica Therapeutics | 317.37M |
| Lineage Cell Therapeutics | 314.12M |
| Inhibikase Therapeutics | 313.58M |